Get the latest Morgan Stanley (MS) stock news and headlines to help you in your trading and investing decisions.

Sanofi's oral BTK inhibitor tolebrutinib is heading towards an FDA decision in September as a potential treatment for multiple sclerosis (MS) after a priority review by the US regulator ...

Sanofi has bolstered the case for its oral BTK inhibitor tolebrutinib as a treatment for multiple sclerosis (MS), due to be filed for approval in the latter half of this year, with new data in a ...

Oxford Weather Forecasts. Weather Underground provides local & long-range weather forecasts, weatherreports, maps & tropical weather conditions for the Oxford area.

Almost two decades after the casino project was announced, Tivoli developers now have site approval from the Mississippi Gaming Commission ...